Is Sinphar Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Sinphar Pharmaceutical pays dividends. Last time was Tuesday 8th of October 2024 where the investors holding the stock on Wednesday 4th of September 2024 were paid TWD1 per share. Over the last 22 times between 2003 and 2024, Sinphar Pharmaceutical has paid TWD10.29229 with an average of TWD0.47 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Sinphar Pharmaceutical 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD17.64, you would have made a profit of TWD13.51 per share or 76.59%
Yes, the average daily trading liquidity for Sinphar Pharmaceutical is TWD357 606 thousand. You should therefore be able to get in and out of your positions relatively fast.
Sinphar Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.21, the company's ability to pay off the debt is normal. Sinphar Pharmaceutical has a good net profit margin of 12.00% and should have high tolerances against inflation.
We have calculated the inflation risk for Sinphar Pharmaceutical to be low [0.4 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.